1 week Ago
ACADIA Pharmaceuticals Inc. ( NASDAQ: ACAD ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Corporate Participants Al Kildani - Senior Vice President, Investor Relations and Corporate Communications Steve Davis - President and Chief Executive Officer Brendan Teehan - Chief Operating Officer, Head of Commercial Kimberly Manhard - Senior Vice President, Global Strategic Planning and Execution Mark Schneyer - Chief Financial Officer Conference Call Participants Tessa Romero - JPMorgan Ritu Baral - TD Cowen Gregory Renza - RBC Capital Markets Ami Fadia - Needham & Company Yatin Suneja - Guggenheim David Hoang - Citigroup Joel Beatty - Baird Elaine Kim - Cantor Jose Lora - Citizens JMP Ash Verma - UBS Marc Goodman - Leerink Sumanth Kulkarni - Canaccord Genuity Uy Ear - Mizuho Operator Good day, everyone, and thank you for standing by. Welcome to the ACADIA Pharmaceuticals First Quarter 2024 Financial Results and Operating Overview Conference Call.
At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to Al-Kildani, Senior Vice President of Investor Relations and Corporate Communications. Please proceed. Al Kildani Thank you.
Good afternoon and thank you for joining us on today's call to discuss ACADIA's first quarter 2024 earnings. Joining me on the call today fr.
